Editas Medicine, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Editas Medicine, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2015 to Q3 2024.
  • Editas Medicine, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$62.1M, a 38% decline year-over-year.
  • Editas Medicine, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$211M, a 7.94% decline year-over-year.
  • Editas Medicine, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$153M, a 30.5% increase from 2022.
  • Editas Medicine, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$220M, a 14.5% decline from 2021.
  • Editas Medicine, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$193M, a 66% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$211M -$62.1M -$17.1M -38% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 -$193M -$67.6M -$27.3M -67.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-04
Q1 2024 -$166M -$62M -$12.9M -26.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-04
Q4 2023 -$153M -$18.9M +$41.9M +68.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$195M -$45M +$10.7M +19.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 -$206M -$40.3M +$13.2M +24.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-04
Q1 2023 -$219M -$49M +$1.48M +2.93% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-04
Q4 2022 -$220M -$60.7M -$19.3M -46.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$201M -$55.7M -$16.6M -42.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 -$184M -$53.5M +$1.8M +3.26% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-03
Q1 2022 -$186M -$50.5M +$6.21M +11% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-03
Q4 2021 -$193M -$41.4M +$21.1M +33.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 -$214M -$39.1M -$46.9M -600% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 -$167M -$55.3M -$31.7M -134% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-02
Q1 2021 -$135M -$56.7M -$19M -50.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-02
Q4 2020 -$116M -$62.5M -$24.7M -65.5% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-26
Q3 2020 -$91.2M $7.82M +$40.8M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$132M -$23.6M +$10.2M +30.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-09
Q1 2020 -$142M -$37.7M -$8.48M -29% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-09
Q4 2019 -$134M -$37.8M -$12.7M -50.8% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-26
Q3 2019 -$121M -$32.9M -$17.7M -116% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-26
Q2 2019 -$103M -$33.8M +$4.94M +12.8% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-26
Q1 2019 -$108M -$29.2M +$1.69M +5.46% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-26
Q4 2018 -$110M -$25.1M +$11.1M +30.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-26
Q3 2018 -$121M -$15.2M +$11.4M +42.7% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-26
Q2 2018 -$132M -$38.7M -$12.3M -46.5% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-26
Q1 2018 -$120M -$30.9M +$158K +0.51% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-26
Q4 2017 -$120M -$36.2M +$3.19M +8.09% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-01
Q3 2017 -$124M -$26.6M -$5.58M -26.5% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-01
Q2 2017 -$118M -$26.4M -$7.4M -38.8% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-01
Q1 2017 -$111M -$31.1M -$13.4M -75.2% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-01
Q4 2016 -$97.2M -$39.4M -$26.7M -212% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-08
Q3 2016 -$70.4M -$21M -$13.6M -184% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-08
Q2 2016 -$56.8M -$19M +$28.5M +60% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-08
Q1 2016 -$85.4M -$17.7M -$12.5M -235% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-08
Q4 2015 -$72.9M -$12.6M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-03
Q3 2015 -$7.41M Jul 1, 2015 Sep 30, 2015 10-K 2017-03-03
Q2 2015 -$47.6M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-03
Q1 2015 -$5.29M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.